New Enterprise Associates related stories
All articles and analysis
Seed investor Ben Narasin sees value in SPV modelFour weeks after the soft launch of Tenacity, Narasin noted on LinkedIn that he already had enough commitments to do a first close.
Precision upskilling platform Workera.ai pockets $16m Series AWorkera.ai, a precision upskilling platform, has secured $16 million in Series A funding.
Metabase takes in $30m Series BMetabase, an open source platform for sharing data and analytics across any business enterprise, has raised $30 million in Series B funding.
Insight Partners leads funding of Tulip InterfacesBoston company Tulip Interfaces raises $100m in Series C funding led by New York-based Insight Partners.
Why now could be emerging managers’ time to shineData suggests emerging managers have struggled during the pandemic, but stats ignore the increasing importance they have to the industry.
How StepStone will integrate Greenspring Associates after the acquisitionAs StepStone looks to expand its VC offering by acquiring Greenspring, the combined firm will make investment decisions by way of a joint investment committee.
VC-backed CVRx rolls out IPOMinneapolis-based CVRx Inc, a medical device firm, has raised about $126 million for its IPO after pricing its 7 million shares at $18 per share.
In growth mode, Wellspring’s rebranded RAYUS Radiology is on a fast consolidation trackFounded as one center in Minneapolis 40 years ago, the company formerly known as Center for Diagnostic Imaging envisions doubling in size over the next two years as it looks to transform the industry with a multi-pronged strategy, CEO Kim Tzoumakas says.
How firms are seizing the opportunity fundsRising valuations and other factors have boosted the alternative strategy in recent years as more venture firms consider adding them to their repertoire. So far, LPs are responding positively.
VC-backed Monte Rosa Therapeutics debuts IPOMonte Rosa Therapeutics Inc, a developer of small molecule precision medicines, has raised about $222.3 million for its IPO after pricing its 11.7 million shares at $19 per share.